NO175714C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estereInfo
- Publication number
- NO175714C NO175714C NO911956A NO911956A NO175714C NO 175714 C NO175714 C NO 175714C NO 911956 A NO911956 A NO 911956A NO 911956 A NO911956 A NO 911956A NO 175714 C NO175714 C NO 175714C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- aromatic esters
- analogous process
- active aromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
- C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/43—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
- C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Emergency Lowering Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/528,967 US5214191A (en) | 1990-05-22 | 1990-05-22 | Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
Publications (4)
Publication Number | Publication Date |
---|---|
NO911956D0 NO911956D0 (no) | 1991-05-21 |
NO911956L NO911956L (no) | 1991-11-25 |
NO175714B NO175714B (no) | 1994-08-15 |
NO175714C true NO175714C (no) | 1994-11-23 |
Family
ID=24107964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO911956A NO175714C (no) | 1990-05-22 | 1991-05-21 | Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere |
Country Status (16)
Country | Link |
---|---|
US (1) | US5214191A (no) |
EP (1) | EP0465802A1 (no) |
JP (1) | JPH04226939A (no) |
KR (1) | KR920005712A (no) |
CN (1) | CN1056680A (no) |
AR (1) | AR248128A1 (no) |
AU (1) | AU640777B2 (no) |
CA (1) | CA2042904A1 (no) |
FI (1) | FI912468A (no) |
HU (1) | HUT58265A (no) |
IE (1) | IE911732A1 (no) |
IL (1) | IL98202A0 (no) |
NO (1) | NO175714C (no) |
NZ (1) | NZ238168A (no) |
PT (1) | PT97727A (no) |
ZA (1) | ZA913727B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5240956A (en) * | 1990-11-07 | 1993-08-31 | Cortech, Inc. | Ester inhibitors |
NZ240442A (en) * | 1990-11-07 | 1994-11-25 | Cortech Inc | 2-heterocyclic substituted aliphatic carboxylic acid esters of (optionally substituted) phenol and pharmaceutical compositions |
US5216022A (en) * | 1991-12-19 | 1993-06-01 | Cortech, Inc. | Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
US5795890A (en) * | 1995-09-27 | 1998-08-18 | Ono Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
WO1997049679A1 (fr) * | 1996-06-27 | 1997-12-31 | Ono Pharmaceutical Co., Ltd. | Derives d'aryle (sulfure, oxyde sulfonique et sulfone) et medicaments les contenant en tant que principe actif |
FR2755015B1 (fr) * | 1996-10-25 | 1998-12-24 | Sod Conseils Rech Applic | Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait |
US6300514B1 (en) | 1997-06-25 | 2001-10-09 | Ono Pharmaceutical Co., Ltd. | Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient |
US6849605B1 (en) | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
AU3511500A (en) | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions |
WO2000051625A1 (en) * | 1999-03-05 | 2000-09-08 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses |
US6355666B1 (en) | 2000-06-23 | 2002-03-12 | Medinox, Inc. | Protected forms of pharmacologically active agents and uses therefor |
AU2001285311B2 (en) * | 2000-08-29 | 2005-09-15 | Biocon, Ltd | Immunoregulatory compounds, derivatives thereof and their use |
US6548099B1 (en) | 2000-11-28 | 2003-04-15 | Hershey Foods Corporation | Process for crystallizing amorphous lactose in milk powder |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
US20040220242A1 (en) * | 2003-05-02 | 2004-11-04 | Leland Shapiro | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions |
TWI328009B (en) | 2003-05-21 | 2010-08-01 | Glaxo Group Ltd | Quinoline derivatives as phosphodiesterase inhibitors |
ES2565848T3 (es) | 2004-07-07 | 2016-04-07 | Biocon Limited | Síntesis de compuestos inmunorreguladores unidos por grupos azoicos |
US7741359B2 (en) * | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
RU2465271C2 (ru) * | 2006-07-18 | 2012-10-27 | Антиб Терапьютикс Инк. | 4-гидрокситиобензамидные производные лекарственных веществ |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA949912A (en) * | 1970-12-01 | 1974-06-25 | Steven P. Cahill | Carriage apparatus for serial printer |
US3954767A (en) * | 1972-05-17 | 1976-05-04 | Esteve Subirana Antonio | Piperazine salts of 2,5-dihydroxy benzene sulfonic acid mono- and diesters |
CH591437A5 (no) * | 1974-05-08 | 1977-09-15 | Esteve Dr Lab Del Sa | |
US4115648A (en) * | 1974-09-13 | 1978-09-19 | Laboratorios Del Dr. Esteve, S.A. | 2,5-Dihydroxy benzene sulfonic acid mono esters |
FR2508033A1 (fr) * | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Aryl-1 aminomethyl-2 cyclopropanes carboxylates (z), leur preparation et leur application en tant que medicaments utiles dans le traitement d'algies diverses |
DE3443308A1 (de) * | 1984-11-28 | 1986-05-28 | Bayer Ag, 5090 Leverkusen | 1-heteroaryl-4-aryl-pyrazolin-5-one zur verwendung als arzneimittel |
-
1990
- 1990-05-22 US US07/528,967 patent/US5214191A/en not_active Expired - Fee Related
-
1991
- 1991-05-16 AU AU77076/91A patent/AU640777B2/en not_active Ceased
- 1991-05-16 NZ NZ238168A patent/NZ238168A/en unknown
- 1991-05-16 ZA ZA913727A patent/ZA913727B/xx unknown
- 1991-05-17 CA CA002042904A patent/CA2042904A1/en not_active Abandoned
- 1991-05-20 KR KR1019910008164A patent/KR920005712A/ko not_active Application Discontinuation
- 1991-05-21 IL IL98202A patent/IL98202A0/xx unknown
- 1991-05-21 IE IE173291A patent/IE911732A1/en unknown
- 1991-05-21 NO NO911956A patent/NO175714C/no unknown
- 1991-05-21 PT PT97727A patent/PT97727A/pt not_active Application Discontinuation
- 1991-05-21 HU HU911703A patent/HUT58265A/hu unknown
- 1991-05-21 FI FI912468A patent/FI912468A/fi not_active Application Discontinuation
- 1991-05-21 EP EP91108206A patent/EP0465802A1/en not_active Ceased
- 1991-05-21 AR AR91319728A patent/AR248128A1/es active
- 1991-05-22 CN CN91103433A patent/CN1056680A/zh active Pending
- 1991-05-22 JP JP3145196A patent/JPH04226939A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HU911703D0 (en) | 1991-12-30 |
HUT58265A (en) | 1992-02-28 |
NO911956D0 (no) | 1991-05-21 |
FI912468A (fi) | 1991-11-23 |
ZA913727B (en) | 1992-02-26 |
NO911956L (no) | 1991-11-25 |
NO175714B (no) | 1994-08-15 |
IL98202A0 (en) | 1992-06-21 |
CN1056680A (zh) | 1991-12-04 |
AU7707691A (en) | 1991-11-28 |
IE911732A1 (en) | 1991-12-04 |
US5214191A (en) | 1993-05-25 |
CA2042904A1 (en) | 1991-11-23 |
JPH04226939A (ja) | 1992-08-17 |
EP0465802A1 (en) | 1992-01-15 |
AU640777B2 (en) | 1993-09-02 |
FI912468A0 (fi) | 1991-05-21 |
KR920005712A (ko) | 1992-04-03 |
AR248128A1 (es) | 1995-06-30 |
NZ238168A (en) | 1995-07-26 |
PT97727A (pt) | 1992-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
NO912672L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer. | |
NO175714C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere | |
NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
NO180084C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
NO900032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
NO178967C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
NO174200C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
FI97136B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi | |
NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler |